Business Context and Reporting Period
Company: Lucid Diagnostics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 11, 2025
Event: Closing of a previously announced underwritten public offering of common stock.
Key Financial Metrics
This filing reports on a capital raise event rather than operational performance metrics. Specific figures include:
- Shares Sold: 14,375,000 shares of common stock.
- Offering Price: $1.20 per share.
- Net Proceeds: Approximately $16.1 million (after underwriting discounts and estimated expenses).
- Use of Proceeds: Working capital and general corporate purposes.
Note: The filing does not provide data on revenue, profit, cash flow, margins, or existing debt levels.
Material Changes
The primary material change is the increase in outstanding common stock and cash liquidity resulting from the offering:
- Capital Structure: Issuance of 14,375,000 new shares, including the full exercise of the underwriters' option to purchase an additional 1,875,000 shares.
- Liquidity: Influx of approximately $16.1 million in net cash proceeds.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to utilize the net proceeds for working capital and general corporate purposes. The offering was executed pursuant to an existing shelf registration statement (Form S-3) filed in November 2022.
Underwriters: Canaccord Genuity LLC acted as sole bookrunner, and Maxim Group LLC acted as co-manager.
Risks and Contingencies: The filing text does not explicitly detail new risks or contingencies beyond the standard disclosure that the press release is not deemed "filed" for Section 18 liability purposes.
Investor Verification Checklist
- Verify the exact number of shares outstanding post-offering to assess dilution impact.
- Confirm the final net proceeds after all transaction expenses are settled.
- Review the Company's most recent 10-K or 10-Q for current cash balances and burn rate to contextualize the $16.1 million raise.
- Check for any lock-up agreements or restrictions on the newly issued shares.